Диссертация (1174355), страница 21
Текст из файла (страница 21)
Two hundred gastrointestinal stromal tumors recurrencepatterns and prognostic factors for survival/ P. De Matteo Ronald, J. Lewis Jonathan,Leung Denis, S. Mudan Satvinder, M. Woodruff James, F. Brennan Murray// Annals ofsurgery.- 2000.- N231 (1).- P.51—57.140. De Vogelaere, K. Laparoscopic resection of gastric gastrointestinal stromaltumors (GIST) is safe and effective, irrespective of tumor size.
K. De Vogelaere, I. VanLoo, O. Peters, A. Hoorens, P. Haentjens, G. Delvaux// Surg Endoscopy.- 2012.- N26.P.2339-45.141. Demetri, G.D. Targeting c-kit mutations in solid tumors: scientific rationaleand novel therapeutic options/ G.D. Demetri // Seminars in oncology.- 2001.- N28(17).- P.19-26.122142. Demetri, G.D. NCCN Task Force report: management of patients withgastrointestinal stromal tumor (GIST) - update of the NCCN clinical practiceguidelines/ G.D.
Demetri, R.S. Benjamin, C.D. Blanke et al// Journal of the NationalComprehensive Cancer Network.- 2007.- N.-5 (2).- P.1-29.143. Dogan, S.S. Ocular side effects associated with imatinib mesylate andperifosine for gastrointestinal stromal tumor/ S.S. Dogan, B. Esmaeli// Hematol OncolClin North Am.- 2009.- Vol.23(1).- P.109-114.144.
Eleftheriadis, N. Submucosal tunnel endoscopy: Peroral endoscopicmyotomy and peroral endoscopic tumor resection/ N. Eleftheriadis, H. Inoue, H.Ikeda, M. Onimaru, R. Maselli, G. Santi// World Journal of GastrointestinalEndoscopy.- 2016.- N8 (2).- P.86–103.145. Fong, Y. Lymph node metastasis from soft tissue sarcoma in adults.Analysis of data from a prospective database of 1772 sarcoma patients/ Y.
Fong, D.G.Coit, J.M. Woodruff, M.F. Brennan// Annals of surgery.- 1993.- N.- 217 (1).- P.72-7.146. Gervaz, P. Surgical management of gastrointestinal stromal tumours/ P.Gervaz, O. Huber, P. Morel// The British journal of surgery.- 2009.-Vol.96, N6.- P.567-78.147. Gluszek, S.
Gastrointestinal stromal tumors/ S. Gluszek, W. Karcz, J.Matykiewicz et al.// Gastroenterol. Pol.- 2004.- N11.- P.17-21.148. Hartley, R.J. Gastro-intestinal stromal tumours (GISTs)-the Pretoriaexperience and literature review: general surgery/ R.J. Hartley, J.H.R. Becker, H. Vander Walt, T.
Luvhengo// South African Journal of Surgery.- 2011.- N49 (3).- Р.128-131.149. He, G. Feasibility of endoscopic submucosal dissection for uppergastrointestinal submucosal tumors treatment and value of endoscopic ultrasonographyin pre-operation assess and post-operation follow-up: a prospective study of 224 casesin a single medical center/ G.
He, J. Wang, B. Chen, X. Xing, J. Wang, J. Chen, Y.He, Y. Cui, M. Chen// Surgical endoscopy.- 2016.- N30 (10).- P.4206-13.150. He, Z. Endoscopic submucosal dissection of large gastrointestinal stromaltumors in the esophagus and stomach/ Z. He, C. Sun, Z. Zheng, Q. Yu, T. Wang, X.123Chen, H. Cao, W. Liu, B.
Wang// Journal of gastroenterology and hepatology.- 2013.N28 (2).- P.262-267.151. Hirota, S. Gastrointestinal stromal tumors: their origin and cause/ S.Hirota// Int J Clin. Oncol.- 2001.- N6.- Р.1-5.152. Hirota, S. Gain-of-function mulation of c-kit in human gastrointestinalstromal tumors/ S. Hirota, K. Isozaki, Y. Moriyama et al.// Scienc.- 1998.- V.6.- Р.577580.153. Holdsworth, C.H. CT and PET: early indicators of response to imatinibmesylate in patients with gastrointestinal stromal tumor/ C.H. Holdsworth, R.D.Badawi, J.B.
Manola, M.F. Kijewski, D.A. Israel, G.D. Demetri, A.D. Van denAbbeele// AJR. American journal of roentgenology.- 2007.- Vol.189 (6).- P. 324-330.154. Hopkins, T.G. Sunitinib in the management of gastrointestinal stromaltumours (GISTs)/ T.G. Hopkins, M. Marples, D. Stark// European Journal of SurgicalOncology.-2008.-N34 (8).- P.844-850.155. Hunt, G.C. Yield of tissue sampling for submucosal lesions evaluated byEUS/ G.C. Hunt, P.P. Smith, D.O. Faigel // Gastroinest Endoscopy.- 2003.- N57.- Р.6872.156. Hwang, J.H. American Gastroenterological Association Institute technicalreview on the management of gastric subepithelial masses/ J.H.
Hwang, S.D. Rulyak,M.B. Kimmey et al.// Gastroenterology.- 2006.- N130.- P.2217-28.157. Inoue, H. Submucosal endoscopic tumor resection for subepithelial tumorsin the esophagus and cardia/ H. Inoue, H. Ikeda, T. Hosoya, M. Onimaru, A. Yoshida,N. Eleftheriadis, R. Maselli, S. Kudo// Endoscopy.- 2012.- N44.- P.225–230.158. Ioannidis, O. Duodenal gastrointestinal stromal tumor presenting withacute upper gastrointestinal bleeding treated with segmental resection/ O. Ioannidis, F.Iordanidis, T.
Fidanis, S. Chatzopoulos, A. Kotronis, G. Paraskevas, A. Konstantara, N.Papadimitriou, A. Makrantonakis, E. Kakoutis // Klinicka onkologie. - 2012. - Vol. –25.- N.- 2.- P. 130-34.124159.Italiano, A. Gastrointestinal stromal tumors: molecular aspects andtherapeutic implications/ A. Italiano, B. Bui // Bulletin du cancer.- 2008.- N95 (1).- P.107-16.160. Jeong, I.H.
Minimally invasive treatment of gastric gastrointestinal stromaltumors: laparoscopic and endoscopic approach/ I.H. Jeong, J.H. Kim, S.R. Lee et al.//Surg Laparosc Endosc Percutan Tech.- 2012.- N22.- P.244-50.161. Joensuu, H. Risk of recurrence of gastrointestinal stromal tumour aftersurgery: an analysis of pooled population-based cohorts/ H.
Joensuu, A. Vehtari, J.Riihimaki, T. Nishida, S.E. Steigen, P. Brabec, L. Plank, B. Nilsson, C. Cirilli, C.Braconi, A. Bordoni, M.K. Magnusson, Z. Linke, J. Sufilarsky, M. Federico, J.G.Jonasson, A.P. Dei Tos, P. Rutkowsky // The lancet oncology.- 2012.- N13 (3).- P. 265274.162. Joensuu, H. Twelve versus 36 months of adjuvant imatinib as treatment ofoperable GIST with a high risk of recurrence: Final results of a randomized trial(SSGXVIII/AIO)/ H. Joensuu, M. Eriksson, J.
Hatrmann et al// Journal of clinicaloncology.- 2011.- N.-29 (suppl. abstr. LBA1).163. Joensuu, H. Gastrointestinal stromal tumour/ H. Joensuu, P. Hohenberger,C.L. Corless// Lancet.- 2013.- N382.- P. 973-83.164. Kim, S.Y. Management of gastric subepithelial tumors: The role ofendoscopy/ S.Y. Kim, K.O. Kim// World Journal Gastrointestinal Endoscopy.- 2016.N8(11).- P.418–424.165. Kobara, H. Indications of endoscopic submucosal dissection forsymptomatic subepithelial or carcinoid tumors originating in the submucosa// H.Kobara, H.
Mori, K. Rafiq, S. Fujihara, N. Nishiyama, M. Ayaki, T. Yachida, J. Tani,H. Miyoshi, H. Kamada, A. Morishita, M. Oryu, K. Tsutsui, R. Haba, T. Masaki//Molecular and clinical oncology.- 2013.- N1 (6).- P.1002-1008.166. Kojima, T. Diagnosis of submucosal tumor of the upper GI tract byendoscopic resection// T. Kojima, H. Takahashi, A. Parra-Blanco et al.// GastrointestEndosc.- 1999.- N50.- P.516-22.125167. Lang, C.C. Features endoscopic ultrasonography and pathology of gastricstromal tumors/ C.C. Lang, Y.H. Li, X.Q. Dong// Zhonghua Xiao Hua Nei Jing Za Zhi.2011.- N6,- P.305-308.168. Li, Q.L. Clinical impact of submucosal tunneling endoscopic resection forthe treatment of gastric submucosal tumors originating from the muscularis proprialayer (with video)/ Q.L. Li, W.F.
Chen, C. Zhang, J.W. Hu, P.H. Zhou, Y.Q. Zhang,Y.S. Zhong, L.Q. Yao, M. D. Xu// Surgical endoscopy.- 2015.- N29 (12).- P.3640-3646.169. Liu, B.R. Endoscopic muscularis dissection for upper gastrointestinalsubepithelial tumors originating from the muscularis propria / B.R. Liu, J.T. Song, B.Qu, J.F. Wen, J.B.
Yin, W. Liu// Surgical endoscopy.- 2012.- N26 (11).- P.3141-3148.170. Lv, X.H. Efficacy and safety of submucosal tunneling endoscopic resectionfor upper gastrointestinal submucosal tumors: a systematic review and meta-analysis/X.H. Lv, C.H. Wang, Y. Xie// Surgical endoscopy.- 2017.- N31 (1).- P.49-63.171.
Mastoraki, A. Metastatic liver disease associated with gastrointestinalstromal tumors: controversies in diagnostic and therapeutic approach/ A. Mastoraki, E.Toliaki, E. Chrisovergi, S. Mastoraki, L.S. Papanikolaou, N. Danias, V. Smyrniotis, N.Arkadopoulos // Journal of gastrointestinal cancer.- 2015.- N46 (3).- P. 237-242.172.
Maydeo, A. Submucosal tunneling and endoscopic resection of a large,esophageal leiomyoma/ A. Maydeo, A. Sharma, S. Bhandari, V. Dhir// Gastrointestinalendoscopy.- 2015.- N82 (5).- P. 954.173. Mazur, M.T. Gastric stromal tumors. Reappraisal of gistogenesis/ M.T.Mazur, H.B. Clark// The American journal of surgical pathology. - 1983.- V.7.- P. 507519.174. Mennigen, R. Segmental resection of the duodenum for gastrointestinalstromal tumor (GIST) / R.
Mennigen, H.H. Wolters, B. Schulte, F.W. Pelster// Worldjournal of surgical oncology.- 2008.- Vol.-6.- P.105.175. Micev, M. Gastrointestinal stromal tumors: a review and considerations onhistogenesis and different diagnosis/ М.
Micev, V. Todorovi, I.Bori, V. Kati // Archviesof oncology. – 2004. - Vol. –12(7).- P. 7-8.126176. Miettinen, M. Gastrointestinal stromal tumors - definition, clinical,histological, immunohistochemical end molecular genetic features and differentialdiagnosis/ M. Miettinen, J. Lazota// Virhows Arch.- 2001.- N438.- P.1-12.177. Miettinen, M. Pathology and diagnostic criteria of gastrointestinal stromaltumors (GISTs): a review / M. Miettinen, M. Majiadi, J. Lasota// European Journal ofCancer.- 2002.- N38 (5).- P.39-50.178. Miettinen, M.
Gastrointestinal stromal tumors, intramural leiomyomas, andleiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, andmolecular genetic study of 167 cases / M. Miettinen, J. Kopczynski, H.R. Makhlouf, M.Sarlomo-Rikala, H. Gyorffy, A. Burke, L.H.
Sobin, J. Lasota // The American journal ofsurgical pathology. – 2003. - Vol.- 27.- N.- 5.- P.625-41.179. Nakano, A. Giant esophageal gastrointestinal stromal tumor: report of acase/ A. Nakano, Y. Akutsu, K. Shuto, M. Uesato, T. Kono, I. Hoshino, N. Akanuma,T. Maruyama, Y. Isozaki, H. Matsubara// Surgery today.- 2015.- N.-45(2).- P.247-52.180. Natoli, C. Tyrosine kinase inhibitors/ C. Natoli, B.
Perrucci, F. Perrotti, L.Falchi, S. Lacobelli // Current cancer drug targets.-2010.-N10 (5).- P.462-483.181. Nichimura, J. Surgical strategy for gastrointestinal stromal tumors:laparoscopic vs. open resection/ J. Nichimura, K. Nakajama, T. Omori, T.Takahashi, A.Nishitani, T. Ito, T. Nishida// Surgical endoscopy.- 2007.- N21.- P.875-78.182. Nilson, B. Gastrointestinal Stromal Tumors: The Incidense, Prevelans,Clinical Course and Prognostication in the Preimatinib Mesilate Era/ B.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
